PositiveReview/Other2018
Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.
Classification Results
AI Classification
PositiveFine-tuned Classification
PositiveAI Classification
PositiveFine-tuned Classification
PositiveUnraveling endocannabinoid signaling disruption in a preclinical model of neurodevelopmental disorders